<?xml version="1.0" ?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="section">
    <meta>
      <identification source="#publicresource">
        <FRBRWork>
          <FRBRthis value="/us-ga/act/ocga/16-13-21"/>
          <FRBRuri value="/us-ga/act/ocga/16-13-21"/>
          <FRBRdate date="2025-12-31" name="enacted"/>
          <FRBRauthor href="#ga-legislature"/>
          <FRBRcountry value="us-ga"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/us-ga/act/ocga/16-13-21/eng"/>
          <FRBRuri value="/us-ga/act/ocga/16-13-21/eng"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#publicresource"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/us-ga/act/ocga/16-13-21/eng/akn"/>
          <FRBRuri value="/us-ga/act/ocga/16-13-21/eng/akn"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#cosilico"/>
        </FRBRManifestation>
      </identification>
      <references source="#cosilico">
        <TLCOrganization eId="ga-legislature" href="/ontology/organization/us-ga/legislature" showAs="Georgia General Assembly"/>
        <TLCOrganization eId="publicresource" href="https://public.resource.org" showAs="Public.Resource.Org"/>
        <TLCOrganization eId="cosilico" href="https://cosilico.ai" showAs="Cosilico"/>
      </references>
    </meta>
    <body>
      <section eId="sec_16_13_21">
        <num>16-13-21</num>
        <content>
          <p>As used in this article, the term:</p>
          <p>(0.5) "Addiction" means a primary, chronic, neurobiologic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include the following: impaired control drug use, craving, compulsive use, and continued use despite harm. Physical dependence and tolerance are normal physiological consequences of extended opioid therapy for pain and are not the same as addiction.</p>
          <p>(Code 1933, § 79A-802, enacted by Ga. L. 1967, p. 296, § 1; Ga. L. 1974, p. 221, § 1; Ga. L. 1978, p. 2237, § 1; Ga. L. 1979, p. 859, § 4; Ga. L. 1980, p. 1746, § 3; Ga. L. 1982, p. 3, § 16; Ga. L. 1982, p. 1264, §§ 1, 3; Ga. L. 1982, p. 2370, §§ 1, 2; Ga. L. 1982, p. 2403, §§ 10, 15; Ga. L. 1984, p. 22, § 16; Ga. L. 1985, p. 149, § 16; Ga. L. 1986, p. 10, § 16; Ga. L. 1986, p. 1555, §§ 1, 2; Ga. L. 1988, p. 1065, § 1; Ga. L. 1999, p. 643, § 5.1; Ga. L. 2003, p. 349, § 1; Ga. L. 2006, p. 125, § 2/SB 480; Ga. L. 2009, p. 859, § 4/HB 509; Ga. L. 2011, p. 659, § 1/SB 36; Ga. L. 2014, p. 353, § 1/SB 134; Ga. L. 2014, p. 866, § 16/SB 340; Ga. L. 2015, p. 5, § 16/HB 90; Ga. L. 2019, p. 1030, § 2/HB 213; Ga. L. 2021, p. 184, § 25/SB 195.)</p>
          <p>The 2019 amendment,
      effective May 10, 2019, in paragraph (16), substituted a comma for the semicolon following "or resin" and "16-13-25;" for "16-13-25 and" in the middle, and added "; and shall not include hemp or hemp products as such terms are defined in Code Section 2-23-3" at the end.</p>
          <p>The 2021 amendment,
      effective July 1, 2021, added the second sentence in paragraph (16).</p>
        </content>
      </section>
    </body>
  </act>
</akomaNtoso>
